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We describe a man who developed pleural effusion with Pasteurella multocida, and review the reported
literature concerning this entity. We identiﬁed 21 such cases, including our own. Most patients with P.
multocida pleural effusions are immunocompromised and/or have signiﬁcant co-morbidities. These ef-
fusions are typically complicated parapneumonic effusions that are grossly purulent (87%) with a low
pleural ﬂuid pH (mean 6.8), high protein (mean 4.8 g/dl) and high LDH (mean 1911 U/L) and low glucose
(28.6 mg/dl). Pleural ﬂuid drainage with tube thoracostomy was required in the majority (62%) of cases.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pasteurella multocida (P. multocida) empyema is a rare clinical
entity. We describe a patient with P. multocida empyema, as well as
analyze all the available reports previously published in the med-
ical literature. We describe the clinical and pleural ﬂuid charac-
teristics of these cases.
2. Methods
We performed a PubMed search for P. multocida empyema using
keywords ‘Pasteurella multocida’, ‘empyema’ and ‘pleural effusion’.
We identiﬁed 20 case reports in addition to our own and present
their pleural ﬂuid ﬁndings in Tables 1 and 2. Themean and standard
deviation (for quantitative variables) are also presented. Findings of
pleural ﬂuid analysis are reported in conventional units wherever
possible.
2.1. Case report
A 75-year-old man was hospitalized for 3 weeks of progressive
shortness of breath. He had a history of an ischemic cardiomyop-
athy and valvular heart disease, and had undergone coronary arteryand Critical Care Medicine,
ge, 47 New Scotland Avenue,
i).
Ltd. This is an open access article ubypass grafting, aortic and mitral valve repair. He also had hyper-
tension, atrial ﬁbrillation and had not been anticoagulated because
of gastrointestinal bleeding. He had end stage renal disease pre-
sumed secondary to hypertension and had required renal
replacement therapy for the last 3 years. Hewas a former smoker of
70 pack-years and had a pet dog.
Physical examination at the time of transfer to medical ICU
showed that he was in mild respiratory distress with temperature
38.2 C, respiratory rate of 18/min, blood pressure 95/54 mmHg,
irregularly irregular pulse 101/min and oxygen saturation 94% on
3L/min supplemental oxygen. Lung auscultation revealed
decreased breath sounds with dullness to percussion at the pos-
terior left base.
Laboratory data included: white blood cell count 16,100 cells/ml,
hemoglobin 9.4 mg/dl, platelet count 152,000/ml. A chest radio-
graph showed a large left pleural effusion. Bedside ultrasonography
revealed a homogeneously echogenic pleural effusion. A small-bore
chest tube was introduced under ultrasound guidance. Purulent
ﬂuid was aspirated.
Pleural ﬂuid analysis showed: pH 7.04, glucose <5 mg/dl, pro-
tein 3.3 gm/dl, LDH 1535 U/L, WBC 45,160/ml with 99% neutrophils,
RBC 12,000/cmm. Pleural ﬂuid Gram stain was negative. Piper-
acillin/tazobactam and linezolid were initiated.
P. multocida was detected on pleural ﬂuid culture within 24
hours that was resistant to ampicillin but sensitive to amoxicillin/
clavulanate. Linezolid was discontinued. Intra-pleural tPA and
DNase were instilled through the chest tube that resulted in
evacuation of the space (total ﬂuid drained ¼ 1.6L) with a residualnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Clinical characteristics and outcomes.
Reference number Age (years) Sex Side of pleural effusion Signiﬁcant comorbidities Chest tube Outcome
[1] 63 M Left None known Yes Death
[2] 8 F Right Noonan syndrome Yes Survived
[3] 57 F Bilateral CHF Yes Survived
[4] 64 F Left Liver cirrhosis Yes Survived
[5] 86 F Left None known No Survived
[6] 69 F Right Liver cirrhosis Yes Death
[7] 54 F Left COPD Yes Survived
[8] 60 M Right None known No Death
[9] 57 F Left Liver cirrhosis, asplenia Yes Death
[10] 85 F Bilateral None known Yes Survived
[11] 65 F Right RA on steroids and methotrexate Yes Survived
[12] 88 M Right None known Yes Death
[13] 90 M Right None known No Survived
[14] 76 M Right Prostate CA, PVD, smoking Yes Survived
[15] 76 F Right None known No Death
[16] 77 M Right None known No Survived
[17] 51 M Right Bronchiectasis and BPF No Survived
[18] 72 F Right Chronic bronchitis No NR
[19] 75 M Bilateral None known No Death
[20] 67 F Right Liver cirrhosis and CHF Yes Death
Present Case 75 M Left ESRD, valvular/coronary disease Yes Death
Mean 67 (±17.7) 40% M, 60% F 57% Right, 29% Left, 14% Bilateral 57% Present, 43% None known 62% Chest tube placed 45% Death
F ¼ Female, M ¼ Male, CHF ¼ congestive heart failure, COPD ¼ chronic obstructive pulmonary disease, RA ¼ rheumatoid arthritis, CA ¼ cancer, PVD ¼ peripheral vascular
disease, BPF ¼ bronchopleural ﬁstula, ESRD ¼ end stage renal disease, NR ¼ not reported.
Table 2
Summary of ﬁndings of pleural ﬂuid analysis.
Reference number Appearance pH Total protein G/DL LDH (U/L) Glucose Mg/DL WBCacount PMN %
1 Purulent NR NR NR NR NR NR
2 Chylous NR 8.8 NR NR 8014 89
3 Purulent NR 12.6 1590 3 10,500 98
4 Serosanguinous NR 3.2 NR 100 19,150 91
5 Purulent 6.53 5.6 403 4 7000 96
6 Purulent 6.69 3 NR 5.4 10,500 98
7 NR 6.9 NR NR 12 5140 NR
8 NR NR NR NR NR NR NR
9 Purulent NR NR NR NR NR NR
10 NR 6.8 4.9 NRb 1.44 160 60
11 NR 7.23 4.3 4209 44 13,900 43
12 Purulent NR 4.2 NR 69 74,888 84
13 Purulent NR 0.004 1676 59 17,100 95
14 Purulent 6.6 3.4 2052 11.7 1800 88
15 Purulent NR NR NR NR NR NR
16 Purulent NR NR NR NR NR NR
17 Purulent NR NR NR NR NR NR
18 NR NR NR NR NR NR NR
19 NR NR NR NR NR NR NR
20 Purulent NR NR NR NR NR NR
Present Case Purulent 7.04 3.3 1535 <5 45,160 99
Meanc 87% Purulent 6.8 ± 0.2 4.8 ± 3.3 1911 ± 1255 29 ± 34 17,776 ± 21,472 86 ± 18
LDH: lactate dehydrogenase; PMN ¼ polymorphonuclear leukocytes; WBC: white blood cell; NR ¼ not reported.
a Pleural ﬂuidWBC count reported in several different units among these references; we therefore displayed the pleural WBC counts in units consistent with the peripheral
WBC count in each reference.
b LDH was elevated but could not be converted to conventional units.
c ±standard deviation, if applicable.
S.N. Jogani et al. / Respiratory Medicine Case Reports 19 (2016) 68e70 69pneumothorax suggestive of lung entrapment (trapped lung
physiology). His dyspnea improved and he was transferred to the
general medical ward. His fever resolved; oxygenation and leuko-
cytosis continued to improve. However, the patient developed
massive gastrointestinal bleeding resulting in cardio-respiratory
arrest leading to death.
3. Discussion
We report the case of an elderly man with P. multocida empy-
ema. He received timely and aggressive antibiotic therapy and
complete drainage of the pleural space. Although therapy resultedin clinical improvement; he died from gastrointestinal bleeding and
cardiac problems.
P. multocida is a gram negative encapsulated non-motile coc-
cobacillus. It forms part of the normal ﬂora in the oropharynx and
nasopharynx but can also be a pathogen [21]. Animal exposure;
usually from the scratch, bite or lick of a domestic cat or dog, is an
important risk factor and is present in most cases of Pasteurella
infection [21,22].
Infection due to P. multocida is usually limited to the skin and
soft tissue with regional complications [23]. P. multocida infection
of the respiratory tract is uncommon, as is pleural infection that has
been described in isolated case reports [22]. We identiﬁed 21
S.N. Jogani et al. / Respiratory Medicine Case Reports 19 (2016) 68e7070published reports, including our own, of P. multocida infected
pleural effusions. In Table 1; we describe the clinical characteristics
and outcome of these cases. Table 1 suggests that most patients
with P. multocida pleural infection have underlying cardiopulmo-
nary disease and/or are immunocompromised (12/21, 57%) and
majority of patients had exposure to animals (15/21, 71%). Pleural
drainage is often required (13/21, 62%) and the condition carries a
high mortality (9/20, 45%).
Table 2 displays the available pleural ﬂuid characteristics of
these patients. The effusions are predominantly complicated par-
apneumonic effusions with 87% (13/15) described as purulent, and
the following pleural ﬂuid ﬁndings: very low pH (mean 6.8), high
protein (mean 4.8 g/dl), high LDH (mean 1911 U/L) and a very low
glucose concentration (mean 28.6 mg/dl). The mean pleural WBC
count in the reported cases was 17,776 and there was a predomi-
nance of polymorphonuclear leukocytes in the largemajority of the
cases (mean 86%, 10/11 cases > 50%). Pleural ﬂuid culture was
positive in 90% of reported cases (18/20).
Our case report and literature review highlight that P. multocida
may cause signiﬁcant pleural disease. Pleural ﬂuid ﬁndings typi-
cally reveal a complicated parapneumonic pleural effusion that
often requires drainage. Pleural infection with P. multocida is often
fatal, which may reﬂect the severity of infection or the moribund
state of the patients who develop this infection.
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